Envista Holdings Corp (NVST)
Health Care / Health Care Supplies
S&P MidCap 400$25.90
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Is Envista Holdings Corp a Good Investment in 2026?
Envista Holdings Corp (NVST) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Envista Holdings Corp as Strong (8/9). The Lynch model is the least favorable, rating it Neutral. Envista Holdings Corp currently trades above its estimated fair value of $20, suggesting limited upside at current prices. Envista Holdings Corp ranks #291 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading slightly above estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
8/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Significantly above fair value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Attractive
Top half (rank 41%)
Frequently Asked Questions
Is Envista Holdings Corp (NVST) a good investment?
What is Envista Holdings Corp's Piotroski F-Score?
Is NVST overvalued or undervalued?
How does NVST compare to other Health Care stocks?
What do investment models say about NVST?
Similar Stocks
Compare NVST with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer